Details for New Drug Application (NDA): 062812

NDA 062812 describes VANCOCIN HYDROCHLORIDE, which is a drug marketed by Ani Pharms and Steriscience and is included in six NDAs. It is available from four suppliers. Additional details are available on the VANCOCIN HYDROCHLORIDE profile page.

The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.

Summary for 062812

Tradename:	VANCOCIN HYDROCHLORIDE
Applicant:	Steriscience
Ingredient:	vancomycin hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 062812

Anti-Bacterial Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Nov 17, 1987	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Nov 17, 1987	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Nov 17, 1987	TE:		RLD:	No

Complete Access Available with Subscription